Plasma chitotriosidase activity in patients with beta-thalassemia.
Barone
Rita
R
Malaguarnera
Lucia
L
Angius
Andrea
A
Musumeci
Salvatore
S
D004791:Enzyme Inhibitors / Q000494:pharmacology; D019143:Evolution, Molecular; D005091:Exons / Q000235:genetics; D020440:Gene Duplication; D005838:Genotype; D006596:Hexosaminidases / Q000097:blood* / Q000172:deficiency / Q000235:genetics; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D007371:Interferon-gamma / Q000494:pharmacology; D007557:Israel / Q000453:epidemiology; D007558:Italy / Q000453:epidemiology; D008070:Lipopolysaccharides / Q000494:pharmacology; D020935:MAP Kinase Signaling System / Q000187:drug effects; D008262:Macrophage Activation / Q000187:drug effects; D008264:Macrophages / Q000201:enzymology*; D011725:Pyridines / Q000494:pharmacology; D012802:Sicily / Q000453:epidemiology; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology; D017086:beta-Thalassemia / Q000201:enzymology / Q000208:ethnology
D004791:Enzyme Inhibitors; D007093:Imidazoles; D008070:Lipopolysaccharides; D011725:Pyridines; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma; D006596:Hexosaminidases; C086400:chitotriosidase; C093642:SB 203580